Mechanism of 6-hydroxydopamine neurotoxicity

Journal of Neural Transmission, Supplement

Volumn , Issue 50, 1997, Pages 55-66

  Glinka, Yelena ^a   Gassen, M ^a   Youdim, M B H ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; FREE RADICAL; NEUROPROTECTIVE AGENT; OXIDOPAMINE; CHELATING AGENT; NEUROTOXIN; SCAVENGER;

ANIMAL MODEL; ANIMAL TISSUE; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; HUMAN; MITOCHONDRIAL RESPIRATION; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REVIEW; ANIMAL; BIOLOGICAL MODEL; BRAIN; DRUG EFFECT; METABOLISM; MITOCHONDRION; NERVE CELL; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; CHELATING AGENTS; FREE RADICAL SCAVENGERS; FREE RADICALS; HUMANS; MITOCHONDRIA; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NEURONS; NEUROTOXINS; OXIDATIVE STRESS; OXIDOPAMINE; OXYGEN CONSUMPTION; PARKINSON DISEASE;

EID: 0030614642     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6842-4_7     Document Type: Review

References (41)

1. Altar CA, Boyland CB, Fritsche M, Jones BE, Jackson C, Wiegand SJ, Lindsay RM, Hyman C (1993) Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions. J Neurochem 63: 1021-1032
2. Andrew R, Watson DG, Best SA, Midgey H, Wenlong H, Petty RKH (1993) The determination of hydroxydopamines and other trace amines in the urine of Parkinsonian patients and normal controls. Neurochem Res 18: 1175-1177
3. Beal MF, Hyman BT, Koroshetz W (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci 16: 125-131
4. Ben-Shachar D, Youdim MBH (1990) Selectivity of melanized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction. J Neural Transm [Suppl] 29: 251-258
5. Ben-Shachar D, Youdim MBH (1991) Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats. J Neurochem 57: 2133-2135
6. Ben-Shachar D, Eshel G, Finberg JPM, Youdim MBH (1991) The iron chelator desferroxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J Neurochem 56: 1441-1444
7. Ben-Shachar D, Zuk R, Glinka Y (1994) Dopamine neurotoxicity: inhibition of mitochondrial respiration. J Neurochem 64: 718-723
8. Cerruti C, Drian MJ, Kamenka JM, Privat A (1993) Protection by BTCP of cultured dopaminergic neurons exposed to neurotoxins. Brain Res 617: 138-142
9. Chadi G, Cao Y, Pettersson RF, Fuxe K (1994) Temporal and spatial increase of astroglial basic fibroblast growth factor synthesis after 6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine neurons. Neuroscience 61: 891-910
10. Cohen G, Werner P (1994) Free radicals, oxidative stress, and neurodegeneration. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 139-162
11. Decker DE, Althaus JS, Buxser SE, VonVoigtlander PF, Ruppel PL (1993) Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine. Res Commun Chem Pathol Pharmacol 79: 195-208
12. Dexter DT, Jenner P, Schapira AHV, Mardsen CD (1992) Alterations in level of iron, ferritin ans other trace metals in neurodegenerative disease affecting basal ganglia. Ann Neurol 32: 94-100
13. Erecinska M, Dagani F (1990) Relationship between the neuronal sodium/potassium pump and energy metabolism. Effects of K+, Na+, and adensine triphosphate in isolated brain synaptosomes. J Gen Physiol 95: 591-616
14. Filloux F, Townsend JJ (1993) Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 119: 79-88
15. Gee P, San RH, Davison AJ, Stich HF (1992) Clastogenic and mutagenic actions of active species generated in the 6-hydroxydopamine/oxygen reaction: effects of scavengers of active oxygen, iron, and metal chelating agents. Free Radic Res Commun 16: 1-10
16. Glinka Y, Youdim MBH (1995) Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur J Pharmacol Environ Toxicol Pharmacol 292: 329-332
17. Glinka Y, Gassen M, Youdim MBH (1996a) Iron and neurotransmitter function in brain. In: Connors JR (ed) Metals and oxidative damage in neurological disorders. Plenum Publishing Corp, New York
18. Glinka Y, Tipton KF, Youdim MBH (1996b) Nature of inhibition of mitochondrial respiratory complex 1 by 6-hydroxydopamine. J Neurochem (in press)
19. Gordon BG, DeBoer JM, Wooldridge LD, Sharp JG (1991) Effect of 6-hydroxydopamine on murine hepatopoetic stem cells: enhanced cytotoxicity on megakaryocyte colony forming units. Life Sci 49: 121-127
20. Inoue A, Ueda H, Nakata Y, Mizu Y (1994) Supersensitivity of quinpirole-evoked GTPase activation without changes in gene expression of D2 and Gi protein in the striatum of hemi-dopaminergic lesioned rats. Neurosci Lett 175: 107-110
21. Karoum F, Chrapusta SJ, Egan MF, Wyatt RJ (1993) Absence of 6-hydroxydopamine in the rat brain after treatment with stimulants and other dopaminergic agents: a mass fragmentographic study. J Neurochem 61: 1369-1375
22. Kebabian JW (1994) Neurotransmitter receptors in neurodegeneration. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 119-128
23. Kienzl E, Puchinger L, Jellinger K, Linert W, Stachelberger H, Jameson RF (1996) The role of the transition metals in the pathogenesis of Parkinson's disease. J Neurol Sci 4766
24. Kita T, Wagner GC, Philbert MA, King LA, Lowndes HE (1995) Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion. Mol Chem Neuropathol 24: 31-41
25. 2+ ions on the slow active/ inactive transition of the mitochondrial NADH-ubiquinone reductase. Biochim Biophys Acta 1098: 144-150
26. Mizuno Y, Ohta S, Tanaka M, Takamiya S, Suzuki K, Sato T, Oya H, Ozawa T, Kagawa Y (1989) Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 163: 1450-1455
27. Mizuno Y, Shin-Ichiro I, Hattori N, Yoshino H (1993) Mitochondria in Parkinson's disease. In: Calne DB, Horowski R, Mizuno Y, Poewe WH, Riederer P, Youdim MBH (eds) Advances in research on neurodegeneration. Birkhäuser, Boston, pp 55-66
28. Monterio HP, Winterbourne CC (1989) 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. Biochem Pharmacol 38: 4144-4182
29. Morel I, Cillard J, Lescoat G, Sergent O, Pasdeloup N, Ocaktan AZ, Abdallah MA, Brissot P, Cillard P (1992) Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine. Free Radic Biol Med 13: 499-508
30. Naveilhan P, Neveu I, Jehan F, Baudet C, Wion D, Brachet P (1994) Reactive oxygen species influence nerve growth factor synthesis in primary rat astrocytes. J Neurochem 62: 2178-2186
31. Offen D, Ziv I, Gorodin S, Barzilai A, Malik Z, Melamed E (1995) Dopamine-induced programmed cell death in mouse thymocytes. Biochim Biophys Acta 1268: 171-177
32. Orrenius S, Nicotera P (1994) The calcium ion and cell death. J Neural Transm [Suppl] 43: 1-11
33. Perumal AS, Gopal VB, Tordzro WK, Cooper TB, Cadet JL (1992) Vitamin E attenuates the toxic effects of 6-hydroxydopamine on free radical scavenging systems in rat brain. Brain Res Bulletin 29: 699-701
34. Sampath D, Jackson GR, Werrbach-Perez K, Perez-Polo JR (1994) Effects of nerve growth factor on glutathione peroxidase and catalase in PC12 cells. J Neurochem 62: 2476-2479
35. Schwartz JP, Nishiyama N (1994) Neurotrophic factor gene expression in astrocytes during development and following injury. Brain Res Bull 35: 403-407
36. Spina MB, Squinto SP, Miller J, Lindsay RM, Hyman C (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of glutathione system. J Neurochem 59: 99-106
37. Stadtman ER (1993) Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Ann Rev Biochem 62: 797-821
38. Ueda H, Sato K, Okumura F, Inoue A, Nakata Y, Yue JL, Mizu Y (1995) Supersensitization of neurochemical responses by L-DOPA and dopamine receptor agonists in the striatum of experimental Parkinson's disease model rats. Biomed Pharmacother 49: 169-177
39. Vroegop SM, Decker DE, Buxser SE (1995) Localization of damage induced by reactive oxygen species in cultured cells. Free Radic Biol Med 18: 141-151
40. Yokoyama C, Okamura H, Ibata Y (1993) Resistance of hypothalamic dopaminergic neurons to neonatal 6-hydroxydopamine toxicity. Brain Res Bulletin 30: 551-559
41. Youdim MBH, Riederer P (1993) The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J Neural Transm [Suppl] 40: 57-67